Journaling through the trip: 5 Questions for ALTERD app founder Sam Suchin
Suchin discusses the making of his altered-states journaling app and how users are employing it.| The Microdose
Suchin discusses the making of his altered-states journaling app and how users are employing it.| The Microdose
Plus: New study questionnaire probes ibogaine experiences and Cannabis company lawsuit could have implications for psychedelics| The Microdose
This week on the Altered States podcast: In 2023, supporters of Brazil’s former president Jair Bolsonaro violently stormed the capital in an attempted coup.| The Microdose
Álvarez and Garcia discuss their documentary film about psilocybin traditions in Mexico.| The Microdose
Plus: California Gov signs bill that will expedite psychedelic research, and volunteer bias in psychedelic research| The Microdose
On the road with Indigenous leaders from the Amazon| themicrodose.substack.com
Plus: The role of ego dissolution in ancient empires and Psychedelic hallucinations compared to those experienced in dementia| The Microdose
Shams and Rolquin discuss the potential implications of passing Compass-specific trigger laws and what Porta Sophia is doing to address them.| The Microdose
Plus: Federal vs. state response to ibogaine, and UK doctors say there’s not yet enough evidence supporting efficacy of psychedelics| The Microdose
What music should accompany a trip?| themicrodose.substack.com
Rockhill discusses Rocky Mountain Poison Control and Drug Safety’s research and how it might inform future psychedelic regulations and policy.| The Microdose
Plus: Psychedelics pilot program bill advances in Massachusetts, and Psychedelics’ effects on non-human primates| The Microdose
This season of the Altered States podcast features 10 deeply-reported, not-to-be-missed stories about psychedelics and the liminal space these substances occupy: Are they party drugs?| The Microdose
The professors discuss the scant evidence for the idea that the Eleusinian Mysteries used psychedelics, and why it persists anyway.| The Microdose
The Latest from Oregon, and Optimi Health files IPO| The Microdose
Hoffman discusses Reunion's clinical trial using RE104 to treat postpartum depression.| themicrodose.substack.com
Plus: Is psilocybin-assisted therapy cost-effective? And Psilocybin for longevity? Or did those tripping mice just eat less?| The Microdose
Plus: HALT Fentanyl Act could make psychedelic research easier, and Senate veterans committee holds “alternative therapies” hearing| The Microdose
Plus: Is Colorado’s next “natural medicine” ibogaine? And how important is the therapy part of psychedelic-therapy?| themicrodose.substack.com
Currie discusses his vision for a psychedelic transportation service.| themicrodose.substack.com
Loyden discusses the process of applying for and receiving The Church of Gaia’s exemption.| themicrodose.substack.com
Day 3 from The Integration.| themicrodose.substack.com
Plus: DEA grants right to use ayahuasca to Spokane, WA church, and New EU funding for psychedelics research| themicrodose.substack.com
Longtime patent attorney David Casimir co-founded the psychedelic prior art database Porta Sophia.| themicrodose.substack.com
